Astellas Pharma Reports Six-Month Net Profit Growth of 63.7%
Group IFRS net profit rose 63.7%; its 2026/27 profit forecast is up 20.1%.
Story updates
06:34:58 AM UTC
SquawkNews
ASTELLAS PHARMA 6-MTH GROUP (IFRS) OPERATING PROFIT 316.56 BLN YEN (+58.8%), 2026/27 FORECA